In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type

Type

Guidance programme

Showing 1 to 10 of 15

TitleConsultationTypeConsultation end date
Modular update to NICE manuals: EQ-5D-5L value setNICE general consultationNICE general
Oveporexton for treating type 1 narcolepsy [ID6622]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Ruxolitinib for treating moderate atopic dermatitis ID6602Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
NICE-wide Topic Prioritisation: the manual (PMG46) 2026 Update ConsultationMethods / process manual consultationNICE process and methods
Efgartigimod for treating chronic inflammatory demyelinating polyneuropathy [ID6409]Draft guidanceTechnology appraisal guidance
Pirtobrutinib for treating relapsed or refractory chronic lymphocytic leukaemia after a BTK inhibitor [ID6269]Draft guidanceTechnology appraisal guidance
Obsessive-compulsive disorder and body dysmorphic disorderTopic engagementQuality standard
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more lines of systemic treatment [ID6388]Final draft guidanceTechnology appraisal guidance
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (managed access review of TA1023) [ID6653]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]Final draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All